Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available)

Product description

Pantoprazole 40 mg/Vial Powder for Solution for Injection
Reference Product: Controloc® / Takeda
Description: Pantoprazoleis a proton pump inhibitor indicated for the treatment of the Gastroesophageal Reflux Disease (GERD) with erosive esophagitis (EE) and in Pathological hypersecretion conditions, including Zollinger-Ellison (ZE) syndrome.
Dossier Status: EU CTD Available
Stability Studies: Zone II / Zone IVb
Shelf life: Three (3) years
Batch Sizes: 24,000 & 32,500 vials
Pack Sizes: BT x 1 vial & x 5 vials
Read more

Specifications

Categories Pharmaceutical Products / ATC coding | Alimentary Tract and MetabolismDrugs for Functional Gastrointestinal Disorders; Finished Dosage FormsInjectables; Contract Services - Contract ServicesLyophilisation
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Greece
Selling Points International Approvals/Standards

More products from ANFARM HELLAS S.A.

View all our products (37)
Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available)

Contact information

Address

Telephone

Website

View all contact information
Curia - From Curiosity to Cure

Curia - From Curiosity to Cure

Datwyler Pharma Packaging

Datwyler Pharma Packaging

Alfasigma  Contract Manufacturing Showroom

Alfasigma Contract Manufacturing Showroom

CONTENT GROUP

CONTENT GROUP

Lonza

Lonza